Celecoxib: a specific COX-2 inhibitor with anticancer properties (Q34608635)

3 August 2017

1 reference

title

Celecoxib: a specific COX-2 inhibitor with anticancer properties (English)

1 reference

3 August 2017

Alane T Koki

1

1 reference

3 August 2017

Jaime L Masferrer

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

9

1 reference

3 August 2017

issue

2 Suppl

1 reference

3 August 2017

page(s)

28-35

1 reference

Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Regulation of cyclooxygenase-2 pathway by HER2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

The role of cyclooxygenases in inflammation, cancer, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Incidence of Cancer Among Patients With Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Nonsteroidal antiinflammatory drugs and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Nonsteroidal antiinflammatory drugs and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

NSAID use and decreased risk of gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Expression of cyclooxygenase-2 in prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Prostaglandins and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Prostacyclin and thromboxane in benign and malignant breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Role of cyclooxygenases in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Hypoxic induction of interleukin-8 gene expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Early cell cycle diacylglycerol (DAG) content and protein kinase C (PKC) activity enhancement potentiates prostaglandin F2 alpha (PGF2 alpha) induced mitogenesis in Swiss 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Prostaglandin F2 alpha-induced mitogenesis in MC3T3-E1 osteoblasts: role of protein kinase-C-mediated tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Carcinogen substrate specificity of human COX-1 and COX-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200902S04

10.1177/107327480200902S04

21 January 2018

Identifiers

DOI

0 references

1 reference